Thank you for the question.
I believe Canada's official position on this is that it does not yet have an official position, which is to say that Canada is sort of officially saying that it's not rejecting the proposal.
To cut right to the chase, countries should be supporting this proposal. Patents and other intellectual property rights have historically been barriers to access to medicines, particularly for people in low and middle-income countries. The TRIPS waiver proposal that's in front of the WTO at the moment is a needed and important mechanism for removing intellectual property rights as being a barrier to accessing COVID-19 technologies. Canada should support it.